Avatrombopag, an oral thrombopoietin receptor agonist: results of two double-blind, dose-rising, placebo-controlled Phase 1 studies-Reference-Cited by-同舟云学术

Avatrombopag, an oral thrombopoietin receptor agonist: results of two double-blind, dose-rising, placebo-controlled Phase 1 studies

Published:2018-09-11 Issue:3 Volume:183 Page:466-478
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Kuter David J.¹^ORCID,Allen Lee F.²

Affiliation:

1. Center for Hematology; Massachusetts General Hospital; Harvard Medical School; Boston MA USA

2. Dova Pharmaceuticals; Durham NC USA

Funder

Dova Pharmaceuticals, Durham, NC, USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15574/fullpdf

Reference15 articles.

1. Pharmacological profile of AS1670542, a novel orally-active human thrombopoietin receptor agonist;Abe;European Journal of Pharmacology,2011

2. Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy;Afdhal;Gastroenterology,2014

3. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura;Bussel;New England Journal of Medicine,2007

4. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia;Bussel;Blood,2014

5. Single and multiple oral doses of AKR-501 (YM477) increase the platelet count in healthy volunteers;Desjardins;The Journal Of Supportive Oncology,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombopoietin Receptor Agonists in Post-Hematopoietic Cell Transplantation Complicated by Prolonged Thrombocytopenia: A Comprehensive Review;ImmunoTargets and Therapy;2024-09

2. A practical guide to the management of immune thrombocytopenia co-existing with acute coronary syndrome;Frontiers in Medicine;2024-04-11

3. Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China;British Journal of Haematology;2024-02-16

4. New thrombopoietin receptor agonist: avatrombopag;Japanese Journal of Thrombosis and Hemostasis;2024

5. Avatrombopag-induced lactic acidosis in a patient with severe thrombocytopenia;BMJ Case Reports;2023-12